Treating circulating cell clusters
Circulating cell clusters found in subjects with cancer, autoimmune conditions, infections, or other diseases, can be trapped or disrupted by filtering them with an intra- or extracorporeal device and, in some cases, exposing them to a substance, such as enzyme, that reduces intercellular adhesion.
1 . A method of removing circulating cancer-associated cell clusters from a subject, the method comprising:
connecting a portion of the subject's blood stream to a system thereby allowing the subject's blood to flow into the system:
wherein the system comprises a filtering module comprising: (a) an input port, (b) an output port, and (c) a membrane having pores configured to allow at least a portion of a subject's blood to pass through the pores from a first side to a second side of the membrane;
wherein the pores in the membrane have a minimum size not less than about 20 microns, configured to allow individual cancer-associated cells to pass through the pores from the first side to the second side of the membrane;
wherein the input port is configured to allow the subject's blood to flow into a first chamber to contact the membrane;
wherein the filtering module is configured to retain circulating cancer-associated cell clusters on the first side of the membrane, each cluster comprising three or more cells; and
wherein the filtering module is configured to allow individual circulating cancer cells in the subject's blood to pass through the pores to the second side of the membrane and into a second chamber and return to the subject's blood circulation via the output port; and
returning blood from the second chamber to the subject's blood circulation via the output port.
2 . The method of claim 1 , wherein the subject is a mammal.
3 . The method of claim 1 , wherein the subject is a human.
4 . The method of claim 1 , further comprising performing the method once or twice a week.
5 . A method of removing circulating cancer-associated cell clusters from a subject, comprising:
introducing a portion of a subject's blood circulation into a filter comprising a membrane having pores that permit at least some of the subject's blood to pass through the pores from a first side to a second side of the membrane;
wherein the pores have a minimum size not less than about 20 microns and are sized and configured to permit individual cancer-associated cells to pass freely through the pores from the first side to the second side of the membrane;
wherein the pores are further sized and configured to prevent circulating cell clusters from passing through the pores, each of the circulating cell clusters comprising three or more cells; and
returning blood from the second side of the membrane to the subject's blood circulation.